The diagnosis of PKAN is established with clinical features and the “eye of the tiger” sign identified on brain MRI and the identification of biallelic pantothenate kinase 2 (PANK2) pathogenic variants on molecular genetic testing. The gene discussed is PANK2; the disease is pantothenate kinase-associated neurodegeneration.